Myricx Bio acquisition

Novartis to acquire Myricx Bio to strengthen next-generation cancer therapy pipeline

The UK biotechnology company’s novel antibody-drug conjugate platform and two preclinical cancer therapy candidates will expand Novartis’ oncology research portfolio.…